Literature DB >> 26825228

E2f4 and E2f5 are essential for the development of the male reproductive system.

Paul S Danielian1, Rex A Hess2, Jacqueline A Lees1.   

Abstract

The E2F transcription factors are primarily implicated in the regulation of entry and exit from the cell cycle. However, in vivo studies have established additional roles for E2Fs during organ development and homeostasis. With the goal of addressing the intestinal requirements of E2f4 and E2f5, we crossed mice carrying Vil-cre, E2f4 conditional and E2f5 germline alleles. E2f4 deletion had no detectable effect on intestinal development. However, E2f4f/f;E2f5+/-;Vil-cre males, but not E2f4f/f;Vil-cre littermates, were unexpectedly sterile. This defect was not due to defective spermatogenesis. Instead, the seminiferous tubules and rete testes showed significant dilation, and spermatozoa accumulated aberrantly in the rete testis and efferent ducts. Our data show that these problems result from defective efferent ducts, a tissue whose primary function is to concentrate sperm through fluid absorption. First, Vil-cre expression, and consequent E2F4 loss, was specific to the efferent ducts and not other reproductive tract tissues. Second, the E2f4f/f;E2f5+/-;Vil-cre efferent ducts had completely lost multiciliated cells and greatly reduced levels of critical absorptive cell proteins: aquaporin1, a water channel protein, and clusterin, an endocytic marker. Collectively, the observed testis phenotypes suggest a fluid flux defect. Remarkably, we observed rete testis dilation prior to the normal time of seminiferous fluid production, arguing that the efferent duct defects promote excessive secretory activity within the reproductive tract. Finally, we also detect key aspects of these testis defects in E2f5-/- mice. Thus, we conclude that E2f4 and E2f5 display overlapping roles in controlling the normal development of the male reproductive system.

Entities:  

Keywords:  E2F4; E2F5; cilia; efferent ducts; fertility; intestine; multiciliated; rete; testis; villin

Mesh:

Substances:

Year:  2016        PMID: 26825228      PMCID: PMC4825840          DOI: 10.1080/15384101.2015.1121350

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.

Authors:  Hugo Garneau; Marie-Christine Paquin; Julie C Carrier; Nathalie Rivard
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

2.  E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.

Authors:  K Moberg; M A Starz; J A Lees
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Ciliogenesis and left-right axis defects in forkhead factor HFH-4-null mice.

Authors:  S L Brody; X H Yan; M K Wuerffel; S K Song; S D Shapiro
Journal:  Am J Respir Cell Mol Biol       Date:  2000-07       Impact factor: 6.914

Review 4.  Multiciliated cells.

Authors:  Eric R Brooks; John B Wallingford
Journal:  Curr Biol       Date:  2014-10-06       Impact factor: 10.834

5.  Aquaporin-1 and -9 are differentially regulated by oestrogen in the efferent ductule epithelium and initial segment of the epididymis.

Authors:  Cleida A Oliveira; Kay Carnes; Luiz R França; Louis Hermo; Rex A Hess
Journal:  Biol Cell       Date:  2005-06       Impact factor: 4.458

6.  E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.

Authors:  P S Danielian; L B Friesenhahn; A M Faust; J C West; A M Caron; R T Bronson; J A Lees
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

7.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.

Authors:  Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng
Journal:  Nat Neurosci       Date:  2009-12-20       Impact factor: 24.884

8.  Cellular and regional distributions of ubiquitin-proteasome and endocytotic pathway components in the epithelium of rat efferent ductules and initial segment of the epididymis.

Authors:  Cleida A Oliveira; Anna Bolivar Victor-Costa; Rex A Hess
Journal:  J Androl       Date:  2009-03-05

9.  Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility.

Authors:  Ben Davies; Claudia Baumann; Christiane Kirchhoff; Richard Ivell; Reinhard Nubbemeyer; Ursula-Friederike Habenicht; Franz Theuring; Ulrich Gottwald
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.

Authors:  Jean-Leon Chong; Pamela L Wenzel; M Teresa Sáenz-Robles; Vivek Nair; Antoney Ferrey; John P Hagan; Yorman M Gomez; Nidhi Sharma; Hui-Zi Chen; Madhu Ouseph; Shu-Huei Wang; Prashant Trikha; Brian Culp; Louise Mezache; Douglas J Winton; Owen J Sansom; Danian Chen; Rod Bremner; Paul G Cantalupo; Michael L Robinson; James M Pipas; Gustavo Leone
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

View more
  19 in total

1.  Defects in efferent duct multiciliogenesis underlie male infertility in GEMC1-, MCIDAS- or CCNO-deficient mice.

Authors:  Berta Terré; Michael Lewis; Gabriel Gil-Gómez; Zhiyuan Han; Hao Lu; Mònica Aguilera; Neus Prats; Sudipto Roy; Haotian Zhao; Travis H Stracker
Journal:  Development       Date:  2019-04-23       Impact factor: 6.868

Review 2.  The development and functions of multiciliated epithelia.

Authors:  Nathalie Spassky; Alice Meunier
Journal:  Nat Rev Mol Cell Biol       Date:  2017-04-12       Impact factor: 94.444

Review 3.  Multiciliated Cells in Animals.

Authors:  Alice Meunier; Juliette Azimzadeh
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

4.  Motile cilia of the male reproductive system require miR-34/miR-449 for development and function to generate luminal turbulence.

Authors:  Shuiqiao Yuan; Yue Liu; Hongying Peng; Chong Tang; Grant W Hennig; Zhuqing Wang; Li Wang; Tian Yu; Rachel Klukovich; Ying Zhang; Huili Zheng; Chen Xu; Jingwen Wu; Rex A Hess; Wei Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-18       Impact factor: 11.205

5.  Transcription factor TAp73 and microRNA-449 complement each other to support multiciliogenesis.

Authors:  Merit Wildung; Tilman Uli Esser; Katie Baker Grausam; Cornelia Wiedwald; Larisa Volceanov-Hahn; Dietmar Riedel; Sabine Beuermann; Li Li; Jessica Zylla; Ann-Kathrin Guenther; Magdalena Wienken; Evrim Ercetin; Zhiyuan Han; Felix Bremmer; Orr Shomroni; Stefan Andreas; Haotian Zhao; Muriel Lizé
Journal:  Cell Death Differ       Date:  2019-05-08       Impact factor: 15.828

6.  Estrogens and development of the rete testis, efferent ductules, epididymis and vas deferens.

Authors:  Rex A Hess; Richard M Sharpe; Barry T Hinton
Journal:  Differentiation       Date:  2020-12-13       Impact factor: 3.880

7.  Control of multiciliogenesis by miR-34/449 in the male reproductive tract through enforcing cell cycle exit.

Authors:  Yu-Jie Wu; Yue Liu; Yan-Qin Hu; Li Wang; Fu-Rong Bai; Chen Xu; Jing-Wen Wu
Journal:  J Cell Sci       Date:  2021-05-11       Impact factor: 5.285

8.  Motility of efferent duct cilia aids passage of sperm cells through the male reproductive system.

Authors:  Isabella Aprea; Tabea Nöthe-Menchen; Gerard W Dougherty; Johanna Raidt; Niki T Loges; Thomas Kaiser; Julia Wallmeier; Heike Olbrich; Timo Strünker; Sabine Kliesch; Petra Pennekamp; Heymut Omran
Journal:  Mol Hum Reprod       Date:  2021-02-27       Impact factor: 4.025

9.  CEP164 is essential for efferent duct multiciliogenesis and male fertility.

Authors:  Mohammed Hoque; Danny Chen; Rex A Hess; Feng-Qian Li; Ken-Ichi Takemaru
Journal:  Reproduction       Date:  2021-07-08       Impact factor: 3.923

Review 10.  Novel functions for the transcription factor E2F4 in development and disease.

Authors:  Jenny Hsu; Julien Sage
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.